|Bid||223.26 x 200|
|Ask||223.30 x 100|
|Day's Range||222.83 - 224.80|
|52 Week Range||156.09 - 231.77|
|PE Ratio (TTM)||25.38|
|Forward Dividend & Yield||3.00 (1.35%)|
|1y Target Est||N/A|
With societal controversies being exposed daily, how long before Americans demand transparency of the US Drug and Healthcare system?
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to UnitedHealth Group, Inc. Here are 5 ETFs with the largest exposure to UNH-US. Comparing the performance and risk of UnitedHealth Group, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
After a divestiture deal that could raise nearly $5 billion for kidney dialysis leader DaVita (DVA) is now 13% higher than the level where Barron's warned that insurers were attacking DaVita's profits ("Insurers Press Dialysis Claims," September 2, 2017). Bulls like John Ransom at Raymond James expect the company to repurchase stock and pay down debt with the proceeds from a December 6 deal to sell its medical practices to UnitedHealth Group (UNH). On December 7, the Raymond James analyst raised his rating on DaVita shares from Outperform to a Strong Buy, while upping his price target from $65 to $84.
Categories: Yahoo FinanceGet free summary analysis UnitedHealth Group, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of UnitedHealth Group, Inc. – Anthem, Inc., Aetna Inc., Cigna Corporation, Humana Inc. and Centene Corporation (ANTM-US, AET-US, CI-US, HUM-US and CNC-US) that have also reported for this period. ... Read more (Read more...)
Hospitals are consolidating at a rapid pace as large medical providers like CVS Health and the Optum unit of UnitedHealth Group expand outpatient services in their markets.
If the GOP eliminates the individual mandate, it'll make a bad situation even worse for millions of folks insured through Obamacare.
Week In Review: Stocks sought direction as Bitcoin's wild ride went into overdrive. CVS is buying Aetna, Broadcom's Qualcomm bid went hostile. First Solar was hot.
On today's episode of the Zacks Friday Finish Line, Content Writer Ryan McQueeney and Editor Maddy Johnson take on this week's biggest stories, including the latest earnings results from Dollar General (DG) and Lululemon (LULU), as well as major healthcare M&A deals involving CVS (CVS), Aetna (AET), and UnitedHealth (UNH).
The Dow endured a volatile week even as Republicans tasted success on the tax legislation front.
Hershey, Humana, Toyota, Amazon and CSX are the companies to watch.